Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Mixed connective tissue disease
ADR ID BADD_A02832
ADR Hierarchy
10      Immune system disorders
10.04      Autoimmune disorders
10.04.04      Autoimmune disorders NEC
10.04.04.007      Mixed connective tissue disease
15      Musculoskeletal and connective tissue disorders
15.06      Connective tissue disorders (excl congenital)
15.06.01      Connective tissue disorders NEC
15.06.01.011      Mixed connective tissue disease
Description A syndrome with overlapping clinical features of systemic lupus erythematosus, scleroderma, polymyositis, and Raynaud's phenomenon. The disease is differentially characterized by high serum titers of antibodies to ribonuclease-sensitive extractable (saline soluble) nuclear antigen and a "speckled" epidermal nuclear staining pattern on direct immunofluorescence. [MeSH]
MedDRA Code 10027754
MeSH ID D008947
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
MCTD | Mixed connective tissue disease | Sharp's syndrome | Mixed Connective Tissue Disease | Connective Tissue Disease, Mixed | Sharp Syndrome | Syndrome, Sharp
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00680Dimethyl fumarate0.001360%
BADD_D01120Ibuprofen--
BADD_D01245Lansoprazole0.000099%
BADD_D01418Methotrexate--
BADD_D01835Pregabalin0.000052%
BADD_D02236Tofacitinib0.000482%
The 1th Page    1    Total 1 Pages